Insomnia Treatment Market: How Top Leading Companies Can Make This Smart Strategy Work – Cole of Duty

In 2025, the market size of the Insomnia Treatment Market is expected to touch million US$ xx million. The revenue registered in 2018 was US$ xx million, thus depicting a growth at a CAGR of xx% from 2018. While in China, the market size was valued at US$ xx million in the forecast base year, further projected to increase up to US$ xx million till the end of 2025, with a CAGR of xx% during forecast period.

In this report, 2018 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Insomnia Treatment .

This report studies the global market size of Insomnia Treatment , especially focusing on the key regions such as United States, European Union, China, and other geographical extents (Japan, Korea, India, and Southeast Asia).

Request Sample Report @https://www.mrrse.com/sample/16585?source=atm

This study presents the Insomnia Treatment market production, revenue, market share, and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. The historical data breakdown for Insomnia Treatment for 2014-2018 is provided in the report along with company projection for 2018 to 2025.

For top companies in United States, European Union, and China, this report investigates and analyzes the production, value, price, market share, and growth rate for the manufacturers, key data from 2018 to 2025.

segmented as follows:

This report encompasses the global insomnia treatment market performance in terms of revenue contribution from various segments and also gives an overview of the insomnia sleep disorder, sleep aids and other definitions. Macro-economic factors influencing growth of the insomnia treatment market along with detailing opportunity analysis of market are also outlined.

A rapidly multiplying geriatric population; increasing prevalence of chronic ailments, growing awareness among patients; and heavy investments in clinical innovation are just some of the factors that are impacting the performance of the global insomnia treatment market.

The global insomnia treatment market is segmented based on drug type, distribution channel and region. On the basis of drug type market has been segmented as OTC drugs and prescription drugs. On the basis of distribution channel market has been segmented as hospital pharmacies, retail pharmacies, e-commerce and drug stores & hypermarkets. A detailed analysis has been provided for each region in terms of market size, Y-o-Y growth rate, absolute $ opportunity, and market attractiveness index. The report also gives a comprehensive overview of the regional market dynamics along with key growth driver, restraints, and trends pertaining to each region, which can be useful to understand the investment and collaboration opportunities in major countries. Key regions assessed in this report include North America, Latin America, Europe, Asia Pacific (APAC), and MEA.

Competitive Landscape

This section is included in the report to provide insights on the key players in the global insomnia treatment market and is primarily designed to furnish a detailed comparative assessment of service offerings and strategies of key providers specific to market segments. Detailed profiles of players in insomnia treatment market are also provided in the report which highlights company description, product/segment overview, SWOT analysis, financial information, key developments related to market and strategic overview.

Research Methodology

To arrive at the market size, Persistence Market Research considered parent market statistics i.e. stem cell market in each region and share of insomnia treatment market. A bottom-up approach was used to validate the total market size obtained. The report provides total revenue of insomnia treatment market over the forecast period 20182026. While forecasting the market size, several factors such as approvals for insomnia treatment drugs, R&D investment by major players, and consumption of drugs by different end users have been considered. However, to quantifying the market across the aforementioned segments and regions, market expectations and opportunities have been considered. In addition, we have taken into consideration the year-on-year growth to understand the predictability of the market and to identify the right growth opportunities in the global insomnia treatment market.

Request For Discount On This Report @ https://www.mrrse.com/checkdiscount/16585?source=atm

The content of the study subjects, includes a total of 15 chapters:

Chapter 1 describes Insomnia Treatment product/service scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2 profiles the top manufacturers of Insomnia Treatment market, with price, sales, revenue and global market share of Insomnia Treatment from 2014 2018.

Chapter 3 analyses the Insomnia Treatment competitive situation, sales, revenue. The global Insomnia Treatment market shares of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4 showcases the Insomnia Treatment breakdown data at the regional level, to discuss the sales, revenue and growth by regions, from 2014 to 2018.

Chapter 5, 6, 7, 8, and 9 emphasize the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2014 to 2018.

Chapter 10 and 11 explain the segments by sales under type and application, with market shares and growth rate under each category, from 2014 to 2018.

Chapter 12 depicts Insomnia Treatment market forecasts by region, type, and application, with sales and revenue projections, from 2018 to 2025.

Chapter 13 and 14 describe Insomnia Treatment sales channel, distributors, customers, research findings and conclusion, appendix, and other data sources.

Buy This Report @ https://www.mrrse.com/checkout/16585?source=atm

More here:
Insomnia Treatment Market: How Top Leading Companies Can Make This Smart Strategy Work - Cole of Duty

CAR T Cell Therapy Market Actual Strategies of Key Players to Overcome COVID 19 Gilead Sciences Inc., Sorrento Therapeutics, Fate Therapeutics Inc. -…

CAR T Cell Therapy Market has witnessed continuous growth within the past few years and is projected to grow even more throughout the forecast period (2020 2027). The analysis presents a whole assessment of the market and contains Future trends, Current Growth Factors, attentive opinions, facts, historical information, and statistically supported and trade valid market information.

The report, titled Global CAR T Cell Therapy Market defines and briefs readers about its products, applications, and specifications. The research lists key companies operating in the global market and also highlights the key changing trends adopted by the companies to maintain their dominance. By using SWOT analysis and Porters five force analysis tools, the strengths, weaknesses, opportunities, and threats of key companies are all mentioned in the report. All leading players in this global market are profiled with details such as product types, business overview, sales, manufacturing base, competitors, applications, and specifications.

You Can Request A Demo Version of Report Before Buying (Higher Preference For Corporate Email ID User): https://www.worldwidemarketreports.com/sample/187550

Gilead Sciences Inc., Sorrento Therapeutics, Fate Therapeutics Inc., Novartis International AG, AbbVie Inc., Adaptimmune Therapeutics PLC, Bluebird Bio, TCR2 Therapeutics Inc., Pfizer Inc., DiaCarta Inc. of the major organizations dominating the global market.(*Note: Other Players Can be Added per Request)

1. Industry outlookThis is where youll find the current state of the CAR T Cell Therapy industry overall and where its headed. Relevant industry metrics like size, trends, life cycle, and projected growth included here. This report comes prepared with the data to back up your business idea. On a regional basis, the Global CAR T Cell Therapy market has been segmented into Asia-Pacific, North America, Europe, Latin America, and the Middle East and Africa.

2. Target marketThis target market section of study includes the following:

User persona and characteristics: It includes demographics such as age, income, and location. It lets you know what their interests and buying habits are, as well as explain the best position to meet their needs.

Market size: How big is the potential CAR T Cell Therapy market for your business? It brings to light the consumption in the CAR T Cell Therapy industry by the type and application.

3. Competitive analysisDiscover your competitors. The report lets you know what youre up against, but it also lets you spot the competitions weaknesses. Are there customers that are underserved? What can you offer that similar businesses arent offering? The competitive analysis contains the following components:

Direct competitors: What other companies are offering similar products and services? Which companies are your true competitors?

Competitor strengths and weaknesses: What is your competition good at? Where do they fall behind? Get insights to spot opportunities to excel where others are falling short.

Barriers to entry: What are the potential pitfalls of entering the CAR T Cell Therapy market? Whats the cost of entry? Is it prohibitively high, or easy to enter?

The window of opportunity:Does your entry into the CAR T Cell Therapy industry rely on time-sensitive technology? Do you need to enter early to take advantage of an emerging market?

4. ProjectionsLikewise, We offered thoughtful, not hockey-stick forecasting.

Market share:We have given the consumption behavior of users. When you know how much can your future customers spend, then only youll understand how much of the CAR T Cell Therapy industry you have a chance to grab, and here we came up with real stats and numbers.

Impact Analysis of COVID-19:The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into account the political, economic, social, and technological parameters.

Finally, It is one report that hasnt shied away from taking a critical look at the current status and future outlook for the consumption/sales of these products, by the end users and applications. Not forgetting the market share control and growth rate of the CAR T Cell Therapy Industry, per application. Most noteworthy, this market analysis will help you find market blind spots.

About WMR

Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends.

Contact Us:

Mr. ShahWorldwide Market ReportsSeattle, WA 98154,U.S.Email: [emailprotected]

See the rest here:
CAR T Cell Therapy Market Actual Strategies of Key Players to Overcome COVID 19 Gilead Sciences Inc., Sorrento Therapeutics, Fate Therapeutics Inc. -...

COVID-19 Impact On Global Stem Cell Therapy Market Research Report Strategies, Shares, Trends, Growth Analysis Forecast to 2027 – Daily Research…

"Global Thoracic Catheters Market Assessment Report: Present & Forecast Evaluation"is a comprehensive blend of qualitative and quantitative analysis in terms of Thoracic Catheters market size, demand, revenue, gross margin, value, and volume. The whole research study is segmented based on regions, product type, application, and top companies operating in Thoracic Catheters Market. The report begins with the introduction on Thoracic Catheters Industry, drivers, restraints, trends, PEST analysis, PORTERs Five Forces analysis. The macro-economic factors, Thoracic Catheters manufacturing cost, industry chain structure and pricing analysis are conducted. The pandemic impact in terms of production, demand, profit, growth scope is covered in our latest report updated in June 2020.

Browse More Details Or Receive Free Sample Copy With Graphs & Charts: https://www.reportscheck.com/shop/2021-2026-report-on-global-thoracic-catheters-market-by-player-region-type-application-and-sales-channel/

The Thoracic Catheters production, market performance over past and present years, opportunity mapping, investment feasibility and growth orbits are specified in this research report. The regional markets share of every industry player, product type and application is studied which is as follows:

Top Companies Involved in Thoracic Catheters Industry are: Medtronic Teleflex Smiths Medical Atrium Medela Redax Atmos Sorin Argon Cook Medical PAHSCO Diversatek

Top Product Types Evaluated are: Catheter Analog Digital

Top Applications studied are: Pneumothorax Pleural Effusion Others

To derive the vital Thoracic Catheters Industry aspects like market share, revenue, production, demand various primary interviews and interactions are carried out with industry experts like VPs, CEOs, Marketing Managers, R&D Managers, distributors, national sales mangers of top companies. Primary and performance analysis is carried out by interviewing the distributors, traders, dealers and more. The most crucial segment like Thoracic Catheters Market competition and trends is studied in this report.

Ask Any Query, Request Custom Information or View Report TOC: https://www.reportscheck.com/shop/2021-2026-report-on-global-thoracic-catheters-market-by-player-region-type-application-and-sales-channel/

The report evaluates the positive and negative impact of ongoing situations on Thoracic Catheters Industry with forecast opportunities and CAGR value. The historical and present industry situations, market trends, technological innovations, regulations, upcoming technologies, and challenges are covered. The Thoracic Catheters Market revenue is expected to surpass US$ XX Million by 2021 with a growth rate of xx.xx% from 2021-2027.

Regional Perspective and Thoracic Catheters Analysis:

The market scope and regional division include North America, Europe, Asia-Pacific, Middle East & Africa, South America, and Rest of the World. The industry presence in the Asia-Pacific region is expected to expand at a good pace due to the increase in production facilities, existing players developing new opportunities and new players emerging in Thoracic Catheters Market. North America is expected to reach a higher market share followed by the European region. Demand for Thoracic Catheters products and its relevant applications across different market segments is growing rapidly.

Thoracic Catheters Market Analysis Based on Top Companies:

After the market competition and overview by top players, company profiles of every Thoracic Catheters Industry player is provided in detail. This segment covers the company overview, business portfolio, production details & description, vital financials, developments, SWOT analysis, and more. Top companies across the globe are profiled in this research study. The report can be customized based on the users choice and more players can be added as per requirements.

The forecast Thoracic Catheters industry vision covers the market size estimation, growth driving factors, risk analysis & mitigation, new entrants SWOT analysis, and investment feasibility.

Key Assessments & Thoracic Catheters Market Research Report Highlights:

Thanks for reading our article. For any queries, questions, or custom requirements feel free to reach us or contact our analyst. We offer the report as per the clients stated scenario.

Contact Us:

Olivia Martin

Marketing Manager

Email: [emailprotected]

Website:www.reportscheck.com

Read the original:
COVID-19 Impact On Global Stem Cell Therapy Market Research Report Strategies, Shares, Trends, Growth Analysis Forecast to 2027 - Daily Research...

Impact of COVID-19 on Autoimmune Treatment Market 20202025 Global Size, Growth, Trends, Applications, Demand Analysis, Key Players and 2025 Forecast…

The launch of novel biomarkers is expected to enhance the autoimmune diagnosis, which is likely to encourage the growth of the global Autoimmune Treatment market in the forecast period. In addition, the technological advancements in laboratory automation platforms and the rising number of product approval and launches are anticipated to accelerate the growth of the market in the coming years.

For Sample Copy of this Report Visit @https://www.orianresearch.com/request-sample/722397

Impact of COVID-19 Outbreak on this Market:

The rise of COVID-19 has brought the world to a halt. We comprehend that this health crisis has brought an unprecedented impact on organizations across industries. However, this too shall pass. Rising helps from governments and several companies can help in the battle against this highly contagious disease. There are few industries that are struggling and some are thriving. Almost every organization is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business to continue and develop COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of corona virus outbreak across industries to help you prepare for the future.

Based on technology, the Autoimmune Treatment market is segmented as bridge therapy, phototherapy, topical therapy, fecal bacteriotherapy, recombinant technology, diseases-modifying antirheumatic drugs, helminthic therapy, and hematopoietic stem cell transplantation. Rheumatoid arthritis leads the global Autoimmune Treatment market, due to high prevalence of rheumatoid arthritis worldwide

Regionally, North America leads the global Autoimmune Treatment market, due to aging population, high incidences of autoimmune diseases, increased healthcare expenditure, and excessive R&D investment for the development of drugs for autoimmune diseases

Global Autoimmune Treatment market is dominated by Abott, Bristol-Myers Squibb Company, Amgen Inc., Pfizer Inc., Bayer AG, F. Hoffmann-La Roche AG, Eli Lilly and Company, Novartis AG, Johnson & Johnson Services Inc., Merck & Co. Inc., Sanofi, GlaxoSmithKline PLC, Biogen, Boehringer Ingelheim GmbH, AstraZeneca PLC, and Astellas Pharma Inc.

Global Autoimmune Treatment Industry is spread across 121 pages, profiling 16 companies and supported with tables and figures.

Inquire more or share a question if any before the purchase on this report @https://www.orianresearch.com/enquiry-before-buying/722397.

Key Benefits of the Report:

* Global, Regional, Country, Insight Type, and Application Market Size and Forecast from 2014-2025

* Detailed market dynamics, industry outlook with market specific PESTEL, Value Chain, Supply Chain, and SWOT Analysis to better understand the market and build strategies

* Identification of key companies that can influence this market on a global and regional scale

* Expert interviews and their insights on market shift, current and future outlook and factors impacting vendors short term and long term strategies

* Detailed insights on emerging regions, Insight Type & Application, and competitive landscape with qualitative and quantitative information and facts

Target Audience:

* Autoimmune Treatment providers

* Traders, Importer and Exporter

* Raw material suppliers and distributors

* Research and consulting firms

* Government and research organizations

* Associations and industry bodies

Order a copy of Global Autoimmune Treatment Market Report 2020 @https://www.orianresearch.com/checkout/722397.

Research Methodology

The market is derived through extensive use of secondary, primary, in-house research followed by expert validation and third party perspective like analyst report of investment banks. The secondary research forms the base of our study where we conducted extensive data mining, referring to verified data sources such as white papers government and regulatory published materials, technical journals, trade magazines, and paid data sources.

For forecasting, regional demand & supply factor, investment, market dynamics including technical scenario, consumer behavior, and end use industry trends and dynamics , capacity production, spending were taken into consideration.

We have assigned weights to these parameters and quantified their market impacts using the weighted average analysis to derive the expected market growth rate.

The market estimates and forecasts have been verified through exhaustive primary research with the Key Industry Participants (KIPs) which typically include:

* Original Equipment Manufacturer,

* Application Supplier,

* Distributors,

* Government Body & Associations, and

* Research Institute

TABLE OF CONTENT

1 Executive Summary

2 Methodology And Market Scope

3 Autoimmune Treatment Market Industry Outlook

4 Autoimmune Treatment Market Application Outlook

5 Autoimmune Treatment Market Technology Outlook

6 Autoimmune Treatment Market Regional Outlook

7 Competitive Landscape

End of the report

Disclaimer

About Us Orian Researchis one of the most comprehensive collections of market intelligence reports on the World Wide Web. Our reports repository boasts of over 500000+ industry and country research reports from over 100 top publishers. We continuously update our repository so as to provide our clients easy access to the worlds most complete and current database of expert insights on global industries, companies, and products. We also specialize in custom research in situations where our syndicate research offerings do not meet the specific requirements of our esteemed clients.

See the original post:
Impact of COVID-19 on Autoimmune Treatment Market 20202025 Global Size, Growth, Trends, Applications, Demand Analysis, Key Players and 2025 Forecast...

COVID-19 Impact On Global Adult Toys Market Research Report Strategies, Shares, Trends, Growth Analysis Forecast to 2027 – Cole of Duty

"Global Stem Cell Therapy Market Assessment Report: Present & Forecast Evaluation"is a comprehensive blend of qualitative and quantitative analysis in terms of Stem Cell Therapy market size, demand, revenue, gross margin, value, and volume. The whole research study is segmented based on regions, product type, application, and top companies operating in Stem Cell Therapy Market. The report begins with the introduction on Stem Cell Therapy Industry, drivers, restraints, trends, PEST analysis, PORTERs Five Forces analysis. The macro-economic factors, Stem Cell Therapy manufacturing cost, industry chain structure and pricing analysis are conducted. The pandemic impact in terms of production, demand, profit, growth scope is covered in our latest report updated in June 2020.

Browse More Details Or Receive Free Sample Copy With Graphs & Charts: https://www.reportscheck.com/shop/2021-2026-report-on-global-stem-cell-therapy-market-by-player-region-type-application-and-sales-channel/

The Stem Cell Therapy production, market performance over past and present years, opportunity mapping, investment feasibility and growth orbits are specified in this research report. The regional markets share of every industry player, product type and application is studied which is as follows:

Top Companies Involved in Stem Cell Therapy Industry are: Osiris Therapeutics NuVasive Chiesi Pharmaceuticals JCRPharmaceutical Pharmicell Medi-post Anterogen Molmed Takeda (TiGenix)

Top Product Types Evaluated are: Autologous Allogeneic

Top Applications studied are: Musculoskeletal Disorder Wounds & Injuries Cornea Cardiovascular Diseases Others

To derive the vital Stem Cell Therapy Industry aspects like market share, revenue, production, demand various primary interviews and interactions are carried out with industry experts like VPs, CEOs, Marketing Managers, R&D Managers, distributors, national sales mangers of top companies. Primary and performance analysis is carried out by interviewing the distributors, traders, dealers and more. The most crucial segment like Stem Cell Therapy Market competition and trends is studied in this report.

Ask Any Query, Request Custom Information or View Report TOC: https://www.reportscheck.com/shop/2021-2026-report-on-global-stem-cell-therapy-market-by-player-region-type-application-and-sales-channel/

The report evaluates the positive and negative impact of ongoing situations on Stem Cell Therapy Industry with forecast opportunities and CAGR value. The historical and present industry situations, market trends, technological innovations, regulations, upcoming technologies, and challenges are covered. The Stem Cell Therapy Market revenue is expected to surpass US$ XX Million by 2021 with a growth rate of xx.xx% from 2021-2027.

Regional Perspective and Stem Cell Therapy Analysis:

The market scope and regional division include North America, Europe, Asia-Pacific, Middle East & Africa, South America, and Rest of the World. The industry presence in the Asia-Pacific region is expected to expand at a good pace due to the increase in production facilities, existing players developing new opportunities and new players emerging in Stem Cell Therapy Market. North America is expected to reach a higher market share followed by the European region. Demand for Stem Cell Therapy products and its relevant applications across different market segments is growing rapidly.

Stem Cell Therapy Market Analysis Based on Top Companies:

After the market competition and overview by top players, company profiles of every Stem Cell Therapy Industry player is provided in detail. This segment covers the company overview, business portfolio, production details & description, vital financials, developments, SWOT analysis, and more. Top companies across the globe are profiled in this research study. The report can be customized based on the users choice and more players can be added as per requirements.

The forecast Stem Cell Therapy industry vision covers the market size estimation, growth driving factors, risk analysis & mitigation, new entrants SWOT analysis, and investment feasibility.

Key Assessments & Stem Cell Therapy Market Research Report Highlights:

Thanks for reading our article. For any queries, questions, or custom requirements feel free to reach us or contact our analyst. We offer the report as per the clients stated scenario.

Contact Us:

Olivia Martin

Marketing Manager

Email: [emailprotected]

Website:www.reportscheck.com

More here:
COVID-19 Impact On Global Adult Toys Market Research Report Strategies, Shares, Trends, Growth Analysis Forecast to 2027 - Cole of Duty

Avalon GloboCare Provides Updates on its Lead Scientific and Clinical Programs in CAR T-Cell Therapy and COVID-19 – GlobeNewswire

July 13, 2020 09:00 ET | Source: Avalon GloboCare Corp.

FREEHOLD, N.J., July 13, 2020 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO), a clinical-stage global developer of cell-based technologies and therapeutics, today announced an update on its four scientific research and clinical development programs in cell therapy and COVID-19 related initiatives, including AVA-001 and AVA-011 (FLASH-CAR), that leverage individualized CAR (Chimeric Antigen Receptor) T-cell therapy for immuno-oncology, as well as AVA-Trapfor mitigating COVID-19 cytokine storm, and S-layer based COVID-19 vaccine development.

AVA-001

Avalon has successfully completed a Phase I first-in-human clinical study of its leading CAR T-cell therapy candidate, AVA-001 (National Institute of Health clinical trial registration number: NCT03952923). AVA-001 is a third generation CAR T-cell therapy which involves the 4-1BB (or CD28) co-stimulation signaling pathway. Nine out of ten patients with relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL) have achieved complete remission (CR rate of 90%) within one month after receiving one dose of AVA-001 CAR T-cell therapy. The treatment with AVA-001 was generally well tolerated with minimal adverse side effects: no neurotoxicity or greater than Grade-1 cytokine release syndrome was observed in this cohort of patients treated with AVA-001. All patients who achieved CR successfully proceeded to allogeneic bone marrow transplant with curative intent. Accessory laboratory testing that accompanied this pilot clinical study has demonstrated evidence of enhancement in CAR T cell persistence and protection against CAR T cell exhaustion. This paradigm of bridging CAR T-cell therapy to bone marrow transplant creates a new therapeutic horizon with curative potential for patients with relapsed/refractory B-ALL and other hematologic cancers. Avalon is in the process of extending AVA-001 CAR T-cell therapy to the next phases of clinical development.

AVA-011 (FLASH-CAR)

Avalons FLASH-CARuses next generation CAR technology to modify patients T-cells and natural killer (NK) cells using a ribonucleic acid (RNA)-based platform rather than a viral vector.Avalons RNA-based CAR technology is designed to rapidly create personalized CAR therapies in 1 to 2 days compared to the 10- to 14-day bio-manufacturing time necessary to generate currently available CAR-T cellular immunotherapy. Avalons FLASH-CARtechnology is also designed to reprogram the immune cells to hone in on multiple crucial cancer cell targets, called tumor antigens, to potentially achieve superior therapeutic effect. Avoiding the use of viral vectors and complicated bio-processing procedures significantly reduces manufacturing costs, resulting in a more affordable and potentially breakthrough therapy for cancer patients. The FLASH-CARtechnology can also be used to generate off-the-shelf, universal cell therapy that has the potential to reach even more patients. Avalons first FLASH-CARplatform candidate, AVA-011, targets both CD19 and CD22 tumor antigens on cancer cells. Pre-clinical research on AVA-011, including tumor cytotoxicity studies, has been successfully completed and Avalon is immediately entering the process development stage to generate clinical-grade CAR-T and CAR-NK cells for use in human clinical trials. Avalon expects to begin a first-in-human clinical trial with AVA-011 for the treatment of relapsed/refractory B-cell lymphoblastic leukemia (B-ALL) and non-Hodgkin lymphoma in the first quarter of 2021. The goal is to apply AVA-011 as a bridge to bone marrow stem cell transplant therapy with curative potential for patients with these blood cancers.

Avalon GloboCare, has established the Avalon Combat COVID-19 Taskforce (ACCT) to expand and accelerate scientific/clinical development on multiple fronts to help combat the COVID-19 global pandemic through a strategic combination of therapeutic and vaccine approaches as follows:

AVA-Trap

Avalon has engaged with Massachusetts Institute of Technology (MIT) to co-develop a QTY therapeutic platform against the cytokine storm which causes lung damage and other organ failure associated with COVID-19. Cytokines are small protein molecules in the body required to regulate and maintain proper physiological functions. In some life-threatening diseases, however, cytokines are released in vast excess (also known as cytokine storm) leading to devastating damage to vital tissues and organs. A prime example is the widely recognized SARS-CoV-2 (COVID-19)-induced cytokine storm, which can lead to acute respiratory distress syndrome, lung fibrosis, multi-organ failure and death. The pre-clinical result has been published in the journal QRB Discovery (Cambridge University Press). Three USPTO provisional patents have been filed based on the unique QTY code protein design platform that uses six water-soluble variant cytokine receptors which have been successfully designed and tested to show binding affinity to the respective cytokines. Avalons AVA-Trap therapeutic program is currently entering animal model testing followed by expedited clinical studies with the goal of providing an effective therapeutic option to combat COVID-19 and other life-threatening conditions involving cytokine storms.

Intranasal and Oral COVID-19 Candidate Vaccine

Formed a strategic partnership program between Avalon GloboCare and the University of Natural Resources and Life Sciences (BOKU) in Vienna, Austria. The goal is to co-develop an S-layer vaccine that can be administered by an intranasal or oral route against SARS-CoV-2 (COVID-19). This partnership is led by BOKUs Professor Uwe B. Sleytr, an eminent member of the Austrian Academy of Sciences, who is a pioneer of applied surface layer (S-layer) nanotechnology, based on the repetitive protein structures that make up the outer surface of microbial cells. This vaccine strategy has the dual advantages of ease of manufacturing and delivery. The candidate vaccine is derived from a fusion of an S-layer viral particle mimic with the SARS-CoV-2 spike protein and could be delivered non-invasively via the nasal or oral passageways, rather than a needle-based injection into the muscle or under the skin. The S-layer protein-based vaccine is expected to both decrease the severity of a SARS-CoV-2 infectionpreventing the more severe respiratory inflammation and organ damage seen in many COVID-19 patientsand build immunity against the virus. Substantial progress has been made by developing the proprietary techniques necessary to synthesize conjugate vaccines consisting of an S-layer artificial viral envelope linked to a viral antigen, eliciting immune-protective antibody responses. Avalon plans to complete the proof-of-concept pre-clinical studies in 2020, followed by first-in-human clinical study of this candidate vaccine during 2021. In addition, Avalon plans to utilize S-layer technology to accelerate additional vaccine programs for other respiratory infections including different strains of the flu (influenza A/B), respiratory syncytial virus (RSV), and other viruses. Avalon is also actively exploring other practical uses of S-layer technology including targeted drug delivery, diagnostic devices, and therapeutic applications.

We are excited and encouraged by the progress in advancing our scientific and clinical programs targeting immune-oncology and COVID-19, stated David Jin, M.D., Ph.D., President and Chief Executive Officer of Avalon GloboCare. As an active, clinical-stage company with innovative technology, productive partnerships and exceptional talent, we are committed to delivering effective execution and leadership to combat cancer and COVID-19, added Dr. Jin.

About Avalon GloboCare Corp.

Avalon GloboCare Corp. (NASDAQ: AVCO) is a clinical-stage, vertically-integrated, leading CellTech bio-developer dedicated to advancing and empowering innovative, transformative immune effector cell therapy, exosome technology, as well as COVID-19 related diagnostics and therapeutics. Avalon also provides strategic advisory and outsourcing services to facilitate and enhance its clients' growth and development, as well as competitiveness in healthcare and CellTech industry markets. Through its subsidiary structure with unique integration of verticals from innovative R&D to automated bioproduction and accelerated clinical development, Avalon is establishing a leading role in the fields of cellular immunotherapy (including CAR-T/NK), exosome technology (ACTEX), and regenerative therapeutics. For more information about Avalon GloboCare, please visit http://www.avalon-globocare.com.

Forward-Looking Statements

Certain statements contained in this press release may constitute "forward-looking statements." Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website (http://www.sec.gov). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, and governmental and public policy changes. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.

Contact Information: Avalon GloboCare Corp. 4400 Route 9, Suite 3100 Freehold, NJ 07728 PR@Avalon-GloboCare.com

Investor Relations: Crescendo Communications, LLC Tel: (212) 671-1020 Ext. 304 avco@crescendo-ir.com

Link:
Avalon GloboCare Provides Updates on its Lead Scientific and Clinical Programs in CAR T-Cell Therapy and COVID-19 - GlobeNewswire

SMD – Scientists discover protective Alzheimer’s gene and develop rapid drug-testing platform – QMUL

10 July 2020

The main challenge in testing Alzheimers drugs in clinical trials is that participants need to have symptoms. But once people have symptoms, it is usually too late for treatments to have a significant effect, as many brain cells have already died.

The only current way to test potential preventative treatments is by identifying participants who are at higher risk of developing Alzheimers and seeing if treatments prevent the onset of their disease. This includes people with Down's syndrome (DS) who have around a 70 per cent chance of developing Alzheimers during their lifetime. This is because the extra chromosome 21 they carry includes the gene for amyloid precursor protein which causes early Alzheimers when overdosed or mutated.

In the study, published in the Nature group journal Molecular Psychiatry, the researchers collected hair cells from people with DS and reprogrammed them to become stem cells, which were then directed to turn into brain cells in a dish.

In these brain-like cells, the researchers saw Alzheimers-like pathology develop rapidly, including the hallmark trio of signs of Alzheimers progression - amyloid plaque-like lesions, progressive neuronal death and abnormal accumulations of a protein called tau inside neurons.

Lead researcher Professor Dean Nietifrom Queen Mary's Blizard Institute commented: This work represents a remarkable achievement, as this is the first cell-based system that has the full trio of Alzheimers-pathologies, without any artificial gene overexpression. This system opens up the prospect for screening for new drugs aimed at delaying or even preventing Alzheimers before neuronal death starts.

The researchers showed that the system could be used as an early preventative-drug testing platform. They took two different drugs which are known to inhibit -amyloid production, tested them on these brain cells, and in six weeks showed that they prevented the onset of Alzheimers-pathology.

Although these two particular drugs have failed clinical trials for other reasons and therefore arent suitable treatments for Alzheimers, the team showed the proof-of-principle that the system can be used on any drug compound, and within six weeks show whether or not it has potential for further investigation.

The team also found proof of the existence of a naturally-functioning Alzheimers suppressor gene (BACE2 gene). Acting in a similar way to tumour suppressor genes in cancer, the increased activity of this gene contributes to the prevention/slowing down of Alzheimers in human brain tissue, and could in the future be used as a biomarker to determine peoples risk of developing the disease, or as a new therapeutic approach by boosting its action.

Professor Dean Nietiexplained: Although its still early days, the system raises a theoretical possibility for further development as a tool to predict who might develop Alzheimers. The same stem cell process could be used on anyones hair follicles, the resulting brain cells of which may or may not then develop Alzheimers-pathology in the dish. The idea would be to catch the people at higher risk of early disease in a cell-based system, before it starts in a persons brain, and allow for the possibilities of individualised preventive interventions. We are still a long way from reaching this goal.

Co-author Professor John Hardy from UCL added: I think we have the potential now to develop a new, human model of the disease which would be a great step forward.

The discoveries in this study were dependent on contributions from people with DS who kindly accepted to participate in this study, the results of which could be beneficial for people with and without DS in preventing Alzheimers. The Downs Syndrome Association (UK) provided essential support and help with recruitment of the participants in the study.

Carol Boys, Chief Executive of the Downs Syndrome Association, said: These are exciting results from an extremely eminent group of researchers and another small step towards a possible intervention and treatment for Alzheimers Disease. The Downs Syndrome Association is delighted to have been able to support this brilliant work.

The main funders of the project were Wellcome (UK) and National Medical Research Council (Singapore), and involved major contributions from the Nanyang Technological University Singapore, UCL (Prof. John Hardy and Prof. Henrik Zetterberg) and Sahlgrenska Academy of the University of Gothenburg, Sweden (Prof. Henrik Zetterberg), as well as a number of international partners, including The Croatian Institute for Brain Research at the University of Zagreb Medical School.

Continue reading here:
SMD - Scientists discover protective Alzheimer's gene and develop rapid drug-testing platform - QMUL

Acute Myeloid Leukemia Treatment Competitive Market Size By Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies And…

New Jersey, United States,- Latest update on Acute Myeloid Leukemia Treatment Competitive Market Analysis report published with extensive market research, Acute Myeloid Leukemia Treatment Competitive Market growth analysis, and forecast by 2026. this report is highly predictive as it holds the overall market analysis of topmost companies into the Acute Myeloid Leukemia Treatment Competitive industry. With the classified Acute Myeloid Leukemia Treatment Competitive market research based on various growing regions, this report provides leading players portfolio along with sales, growth, market share, and so on.

The research report of the Acute Myeloid Leukemia Treatment Competitive market is predicted to accrue a significant remuneration portfolio by the end of the predicted time period. It includes parameters with respect to the Acute Myeloid Leukemia Treatment Competitive market dynamics incorporating varied driving forces affecting the commercialization graph of this business vertical and risks prevailing in the sphere. In addition, it also speaks about the Acute Myeloid Leukemia Treatment Competitive Market growth opportunities in the industry.

Acute Myeloid Leukemia Treatment Competitive Market Report covers the manufacturers data, including shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including Acute Myeloid Leukemia Treatment Competitive market size, volume and value, as well as price data.

Acute Myeloid Leukemia Treatment Competitive Market competition by top Manufacturers:

Acute Myeloid Leukemia Treatment Competitive Market Classification by Types:

Acute Myeloid Leukemia Treatment Competitive Market Size by End-user Application:

Listing a few pointers from the report:

The objective of the Acute Myeloid Leukemia Treatment Competitive Market Report:

Cataloging the competitive terrain of the Acute Myeloid Leukemia Treatment Competitive market:

Unveiling the geographical penetration of the Acute Myeloid Leukemia Treatment Competitive market:

The report of the Acute Myeloid Leukemia Treatment Competitive market is an in-depth analysis of the business vertical projected to record a commendable annual growth rate over the estimated time period. It also comprises of a precise evaluation of the dynamics related to this marketplace. The purpose of the Acute Myeloid Leukemia Treatment Competitive Market report is to provide important information related to the industry deliverables such as market size, valuation forecast, sales volume, etc.

Major Highlights from Table of contents are listed below for quick lookup into Acute Myeloid Leukemia Treatment Competitive Market report

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Read more from the original source:
Acute Myeloid Leukemia Treatment Competitive Market Size By Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies And...

Global Stem Cell Therapy Market 2020: Features, Trends, Consultants, International Statistics, Demand Analysis and Business Opportunities till 2025 -…

Global Stem Cell Therapy market In-Depth Research Report, added by Adroit Market Research in its huge repository, offers a brilliant, comprehensive research study of the market. The report includes a thorough study of key market dynamics, including growth drivers, restraints, and opportunities. It focuses mainly on current and historical market scenarios. It understands market competition, segmentation, geographic expansion, regional growth, market size, and other factors. The Stem Cell Therapy research study will certainly benefit investors, market players, and other market participants. They will get a sound understanding of the worldwide market and the industry.

Get sample copy of Stem Cell Therapy Market report @ https://www.adroitmarketresearch.com/contacts/request-sample/691

The insight has been added in the report to provide realistic overview of the industry, consist of Stem Cell Therapy market manufacturers data, price, revenue, gross profit, business distribution, etc., SWOT analysis, recent developments and trends, drivers and restrain factors, company profile, investment opportunity, demand gap analysis, forecast market size value/volume, services and product, Porters Five Models, socioeconomic factors, government regulation in Stem Cell Therapy industry.

Read complete report with TOC at: https://www.adroitmarketresearch.com/industry-reports/stem-cell-therapy-market

The Stem Cell Therapy market is segmented according to component, application area, type, organization size, end use Industry and region. A complete explanation of the market accumulating methodology, the use of advancement, conclusions of the world market players has been given. The segmentation study identifies leading segments and explains key factors supporting their growth in the global Stem Cell Therapy market. The competitive landscape of the global Stem Cell Therapy market is broadly studied in the report with large focus on recent developments, future plans of top players, and key growth strategies adopted by them.

Global Stem Cell Therapy market is segmented based by type, application and region.

Based on Type, the market has been segmented into:

Based on cell source, the market has been segmented into,

Adipose Tissue-Derived Mesenchymal SCs Bone Marrow-Derived Mesenchymal SCs Embryonic SCs Other Sources

Based on application, the market has been segmented into:

Based on therapeutic application, the market has been segmented into,

Musculoskeletal Disorders Wounds & Injuries Cardiovascular Diseases Gastrointestinal Diseases Immune System Diseases Other Applications

The research report on global Stem Cell Therapy market ensures users to remain competitive in the market. Also report helps to identify the new innovations and developments by existing key players to increase the growth of the Stem Cell Therapy market. Study report covers all the geographical regions where competitive landscape exists by the players such as North America, Europe, Latin America, Asia-Pacific and Middle East Africa. Thus Stem Cell Therapy market report helps to identify the key growth countries and regions.

In addition, report presents quantitative as well as qualitative narration of global Stem Cell Therapy market. The research report is beneficial for researchers, strategy managers, academic institutions and analysts. Thus report helps all types of users to identify the strategic initiatives so that they can understand how to expand the global Stem Cell Therapy market business across the globe for the product development. Moreover, research report provides in depth analysis of all the segments which can impact on the market growth.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert @ https://www.adroitmarketresearch.com/contacts/enquiry-before-buying/691

About Us :

Adroit Market Research is an India-based business analytics and consulting company. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a markets size, key trends, participants and future outlook of an industry. We intend to become our clients knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.

Contact Us :

Ryan Johnson Account Manager Global 3131 McKinney Ave Ste 600, Dallas, TX 75204, U.S.A Phone No.: USA: +1 972-362 -8199 / +91 9665341414

See original here:
Global Stem Cell Therapy Market 2020: Features, Trends, Consultants, International Statistics, Demand Analysis and Business Opportunities till 2025 -...

Woman runs the width of Scotland in her conservatory – Runner’s World (UK)

A Lancashire woman has run the width of Scotland in her conservatory in just over 70 hours.

Star Bickerstaff, ultrarunner and mother-of-four, embarked on the Virtual Race Across Scotland on Saturday evening. Covering 215 miles on her personal treadmill, she placed third overall and earned the title of the winning female in the early hours of Tuesday morning.

Star began racing over five years ago, to raise money for her father Pauls multiple sclerosis healthcare. She aimed to reach a sum of 40,000 to fund a potentially life-saving stem cell treatment and had hoped that her most recent ultramarathon would bring the family closer to this goal.

Sadly, Paul passed away before he could see his daughter complete the race. Despite this devastating loss, Star went through with the event and has donated all the money she raised to the Blind Veterans Llandudno Centre in Wales, who provided respite for both her mum and dad when she was growing up.

When Star entered her first 10K in 2015, she was less than confident in her fitness. But to her surprise, she crossed the line in under an hour. 'I had this realisation that I was far more capable of pushing myself than Id thought,' she says. 'I was hooked!'

When she was unable to secure a place in the 2016 London Marathon, Star decided to expand her options and consider the possibility of longer races. While most people would be daunted by the increase in mileage, Star was intrigued.

'I just thought "this cant be possible people can't survive this kind of thing",' says Star. But after crawling down a YouTube rabbit hole of ultra-running videos, she was converted. In March 2017, she signed up for the Jurassic Coast Challenge, a colossal race of three marathons in three days.

Every runner knows that the key to racing well is preparation, and this is especially true when it comes to extreme distances. Star committed to a strict training regime, refusing to allow the obstacles of the pandemic to trip her up on the path to accomplishing her goal.

Im of the mindset that if you want to be good at something you need to practise that thing"

With no access to the gym or her personal trainer, Star was forced to get creative to maintain her strength training.

Luckily for her, she says she didnt have to look too far for inspiration: 'When the lockdown started, I started using my children as weights!'

Due to her fathers health condition, lengthy outdoor runs were another no-go. Star adapted her plans and proceeded to clock up the mileage from home, where she alternated between running on a treadmill and tending to her dads needs.

Her intense training may seem drastic to some, but when it comes to diet, Star is anything but extreme. While she makes sure to consume plenty of vegetables and protein sources, she does not deprive herself when shes peckish for a treat.

'Whilst doing any ultra I just eat whatever Im craving then because I feel like it is my body's way of telling me what I need,' she explains.

And her go-to snack during her latest venture? 'Pringles! So many pringles!'

Like many athletes during lockdown, Star was faced with an entirely new challenge completing a virtual race.

Without the scenic distractions and spectators support, the inevitable low points of an ultramarathon can feel especially tough.

Star pinpoints the last night of the race as particularly painful, and not just because of the physical toil.

'As it got dark and my fianc had gone to bed, I was on my own, so I started thinking about my dad and got quite emotional,' she recalls. 'He knew I was taking on this challenge and he wouldn't be there when I finished.'

Despite her overwhelming grief and aching limbs, Star persevered and kept her eye fixed on the tracker.

'When I saw I was doing pretty well, I just decided that I wasn't going to sleep.'

Resisting the temptation of a snug bed in favour of the treadmill is no easy task, but it certainly paid off. Not only did Star complete the race in 70 hours, she was the first female to cross the line. Overall, she placed 3rd out of 71 participants, crossing the line at 6.23am on Tuesday morning.

Star emerged from the race with blistered toes, but her humility firmly intact. 'Im by no means the fastest,' she says. 'But Im very determined and dont ever like to quit.'

This unyielding grit is something she learned from her fathers own courage and endurance. 'Before my dad got ill, he used to run all the time with a 60 pound backpack on,' says Star. 'Anytime it got hard I just thought about him and how Id never in my life seen my dad give up.'

When it comes to motivation, Star is a proponent of mind over matter. To those who may be fearful of attempting such lofty challenge, she emphasises the importance of rewiring negative thought patterns.

'I never think about how I cant do something, but how I can,' she says. 'Just realise that its going to be hard work and be okay with that.'

If you think running for 70 hours may put someone off the sport for life, think again. This major accomplishment has only inflamed Stars passion, nudging her to look further afield for her next race.

Once the pandemic is over, she hopes to take on another ultra on the other side of the Atlantic. 'One dream of mine is to try and cover the Pacific Crest Trail in America, it looks beautiful,' she says.

And while the Virtual Race Across Scotland may be over, Star is by no means finished with her neighbouring nation. She already plans to enter the same event in 2021, by which stage we hope she gets the scenery and crowd cheers that she so greatly deserves.

This man ran an entire marathon.. on his balcony

Why people are running marathons in gardens

This content is created and maintained by a third party, and imported onto this page to help users provide their email addresses. You may be able to find more information about this and similar content at piano.io

This commenting section is created and maintained by a third party, and imported onto this page. You may be able to find more information on their web site.

Excerpt from:
Woman runs the width of Scotland in her conservatory - Runner's World (UK)